RE:RE:RE:Delay of q2On July 15,2020 WeedMD never gave a status on Q2--------Here what they said: ----------------------Corporate Highlights During & Subsequent to First Quarter Ended March 31, 2020 Launches Cannabis 2.0 Product Line Of Medical Vaporizers Strain-Specific Medicinal Vaporizer Pens (Vapes): In June 2020, WeedMD completed the launch of its innovative line of strain-specific medicinal vapes. The Aurum vapes are available to Starseed patients across Canada as part of the Companys expanding medical cannabis product portfolio. The Aurum vapes are produced and formulated in-house at WeedMDs extraction hub CX Industries with premium cannabis extracts derived from biomass cultivated from the Companys indoor and outdoor harvests. The new product line was launched with the Companys high-regarded Ghost Train Haze strain, to be followed by other strains and formulations as well as a launch in the adult-use market under WeedMDs Color Cannabis brand. Outdoor Cultivation Enters Second Year Outdoor Cultivation: WeedMD completed the planting of 18,000 clones across seven core cultivars on its 27-acre outdoor field in June, making WeedMD one of only a handful of licensed-producers entering its second year of outdoor operations. The harvest is expected to support CX Industries with cannabinoid-rich, low cost cannabis biomass, and provide attractive input material for certain flower and extract products. Business Development Milestones Expanded Medical Channel: With the addition of Starseed, WeedMD also welcomed new and direct channels to a patient base with insurance coverage for medical cannabis. The potential access to a substantial and direct consumer audience of over 350,000 individuals is expected to drive growth and margin expansion. Four new partners and their benefits providers were added in February 2020: LiUNA Local 1059 (London, Ontario) The International Union of Painters and Allied Workers The Insulators Local 95 Health and Welfare Trust Fund myHSA PatientDirect Kicks Off With Express Delivery to Toronto-Area Patients Same-Day Delivery Service: In June 2020, WeedMD launched its same-day medical cannabis home delivery service. The pilot project called PatientDirect services local patients in the greater Toronto-area, with order fulfillment from the Companys Bowmanville, Ontario distribution centre located just outside Toronto. PatientDirect is intended to ease potential third-party postal and delivery service disruptions resulting from current business conditions. The service is being offered to new and existing Starseed Medicinal patients and will expand to WeedMD patients. Strengthens Balance Sheet and Adds Financial Flexibility Senior Secured Credit Facility: At the end of the second quarter, WeedMD amended certain terms of its senior secured credit facility entered into on March 29, 2019 (the Credit Facility) (the Credit Agreement Amendment). Under the terms of the Credit Agreement Amendment, the Company secured a deferral of certain financial covenants by 12 months to June 30, 2021 and quarterly principal repayments are rescheduled to commence at the end of 2020. Additionally, the Company agreed to a 50 basis point increase in the applicable interest rate margin on the Credit Facility. $25 Million Strategic Equity Investment: WeedMD secured a $25 million strategic equity investment from the LiUNA Pension Fund of Central and Eastern Canada following receipt of shareholder approval in February 2020. Leadership Appointments Following the acquisition of Starseed, WeedMD combined its experienced senior leadership team and board of directors and in February 2020 in order to accelerate the Companys commercial growth, appointed Angelo Tsebelis as CEO of WeedMD. Formerly President of WeedMD and Starseed, Angelo brings a renewed focus on expanding strategic commercial and sales distribution initiatives to execute on delivering high-margin, quality products. In April 2020, the Company appointed Lincoln Greenidge as Chief Financial Officer. Lincoln brings over 20 years of corporate finance, capital markets as well as mergers and acquisition experience and is leading the Companys financial integration and strategic shift to commercialize WeedMDs cultivation platform. COVID-19 Operational Response In response to the COVID-19 global pandemic, WeedMD established a number of safety protocols and risk mitigation strategies to ensure the health and safety of its employees and communities. The Company temporarily closed its corporate offices in London and Toronto in accordance with emergency measures enacted by the Province of Ontario - with applicable employees adopting a work-from-home policy that remains in effect until further notice. While its production sites continue to operate, employees are observing strict social distancing and safety measures put in place by the Company. WeedMD also introduced cost-leadership tactics that included salary reductions across its senior leadership levels. The Company also confirmed in March 2020 that it donated over 23,000 face masks and gloves in varying sizes to Ontario-area hospitals in need during that time.